Status:

COMPLETED

Post Colposcopy Management of ASC-US and LSIL Pap Tests

Lead Sponsor:

University of Calgary

Conditions:

Cervical Cancer Screening

Eligibility:

FEMALE

18+ years

Phase:

NA

Brief Summary

There is weak evidence supporting optimal follow-up of women with ASC-US or LSIL cytology found to have low grade disease or normal findings at initial colposcopy. Surveillance options include continu...

Detailed Description

1\. BACKGROUND In 2010 the estimated age standardized incidence and mortality rates for cancer of the uterine cervix in Canada were 7 and 2 per 100,000 women respectively. Squamous cell carcinoma is t...

Eligibility Criteria

Inclusion

  • One previous routine screening Pap test showing ASC-US, HPV positive
  • Two previous consecutive routine screening Pap tests showing ASC-US or LSIL

Exclusion

  • previous hysterectomy
  • pregnant or considering pregnancy in the next 18 months
  • had a previous excisional or ablative procedure of the cervix
  • younger than 18.

Key Trial Info

Start Date :

January 1 2012

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

August 1 2012

Estimated Enrollment :

133 Patients enrolled

Trial Details

Trial ID

NCT03466710

Start Date

January 1 2012

End Date

August 1 2012

Last Update

May 2 2018

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.

Post Colposcopy Management of ASC-US and LSIL Pap Tests | DecenTrialz